Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000486478 | SCV000568947 | likely pathogenic | not provided | 2017-01-09 | criteria provided, single submitter | clinical testing | A variant that is likely pathogenic has been identified in the SCN4A gene. The c.1996_2001dupTCTGTG variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.1996_2001dupTCTGTG variant results in an in-frame duplication of a Serine and Valine residue, denoted p.Ser666_Val667dup. The c.1996_2001dupTCTGTG variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The c.1996_2001dupTCTGTG variant results in the duplication of two conserved residues predicted to be at the junction of the extracellular loop before transmembrane segment S4 and that transmembrane segment in the second homologous domain of the SCN4A protein. Additionally, missense variants in nearby residues (R669H, F671S, R672S/G/C/H) have been reported in the Human Gene Mutation Database in association with SCN4A-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. |